NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $236,704 | -23.3% | 2,441 | -24.0% | 0.12% | -31.0% |
Q3 2023 | $308,738 | -2.8% | 3,211 | 0.0% | 0.17% | -6.7% |
Q2 2023 | $317,728 | +3.2% | 3,211 | 0.0% | 0.18% | -2.7% |
Q1 2023 | $307,805 | +5.1% | 3,211 | 0.0% | 0.18% | -7.0% |
Q4 2022 | $292,902 | +36.2% | 3,211 | +13.9% | 0.20% | +28.4% |
Q3 2022 | $215,000 | -10.8% | 2,818 | 0.0% | 0.16% | -6.6% |
Q2 2022 | $241,000 | -3.2% | 2,818 | -1.1% | 0.17% | +2.5% |
Q1 2022 | $249,000 | -2.4% | 2,849 | 0.0% | 0.16% | -3.0% |
Q4 2021 | $255,000 | +8.1% | 2,849 | 0.0% | 0.17% | -2.9% |
Q3 2021 | $236,000 | -9.6% | 2,849 | -0.6% | 0.17% | -13.1% |
Q2 2021 | $261,000 | +6.1% | 2,867 | +1.1% | 0.20% | -2.5% |
Q1 2021 | $246,000 | -1.6% | 2,836 | +0.6% | 0.20% | -15.8% |
Q4 2020 | $250,000 | +2.0% | 2,818 | 0.0% | 0.24% | -9.7% |
Q3 2020 | $245,000 | -0.4% | 2,818 | 0.0% | 0.27% | -2.6% |
Q2 2020 | $246,000 | +7.0% | 2,818 | +2.7% | 0.27% | -4.2% |
Q1 2020 | $230,000 | +5650.0% | 2,744 | +6136.4% | 0.29% | +7050.0% |
Q4 2019 | $4,000 | – | 44 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |